Breast cancers may bear up to 25–50 copies of the HER2 gene, resulting in an estimated number of two million receptors expressed at the tumor cell surface (Kallioniemi et al., 1992), while a normal cell surface has much less HER2 receptors. This evidence concerns the gene ERBB2 and breast carcinoma.